This medicines update is provided by the Veterinary Medicines Directorate (VMD) and lists new active substance, new marketing authorisations and changes to authorisations most relevant to vets. New marketing authorisations The following are for products authorised for use in horses: Subestin 25 microgram/ml Oral Solution for Horses Clenbuterol Hydrochloride Floris Animal Health Limited Authorised in GB, POM-V, Respiratory expectorant RenuTend suspension for injection for horses Tenogenic primed

At the VMD’s first Equine Anthelmintic Resistance Stakeholder Workshop held in November 2021, stakeholders agreed that a pan-industry equine group is essential to lead a coordinated approach to anthelmintic use and stewardship in the UK equine sector. Following on from the success of the Workshop the VMD hosted a follow up meeting on 15 March 2022 to discuss the next steps to forming this new pan-industry equine group. There was continued enthusiasm and broadening interest in the formation

This medicines update is provided by the Veterinary Medicines Directorate (VMD) and lists new active substance, new marketing authorisations and changes to authorisations most relevant to vets. Changes to authorisations most relevant to vets The changes to authorisations most relevant to vets can be found below. Each product listed, along with the authorisation holder, distribution category and details of which Summary of Product Characteristics sections have been revised/changed. All entries ca